DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

Clinical trial NCT02094833 · COMPLETED

Trial details

NCT number: NCT02094833
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Haemophilus Influenzae Type b Infection Poliomyelitis Hepatitis B

Start date: 2014-03-01
Primary completion: 2016-04-01
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.